Mid‐term outcomes of valve replacement surgery with or without coronary artery bypass grafting in patients with overweight and obesity: A cohort study
Clinical Obesity · 2025
DOI: 10.1111/cob.12710 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Obesity, 2025. Verfasst von Nadia Rajablou und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Coronary Artery Bypass, Obesity, Heart Valve Prosthesis Implantation, Overweight. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
Current data evaluating outcomes of valve replacement surgery in patients with overweight/obesity is contradictory. There is a scarce study comparing outcomes of valve surgery considering the type of valve involved in the procedure. We followed outcomes in patients with overweight and obesity after valve replacement surgery with or without coronary artery bypass graft (CABG) and also patients with aortic valve replacement (AVR) and mitral valve replacement (MVR), separately to compare their mid‐term prognosis in each group. Consecutive patients who had undergone cardiac valve surgery with or without CABG in Tehran Heart Center were enrolled. We enrolled 3158 patients. Median survival was 125.71 ± 82.20 weeks in patients with overweight/obesity. We found a significantly higher LVDd, LVDs and RVDd in patients with CABG (51.85 ± 7.31, 36.80 ± 8.81 and 30.04 ± 3.58, respectively) compared to the valve group (50.10 ± 6.35 mm, 35.08 ± 7.29 mm and 29.76 ± 4.07 mm, respectively). All‐cause mortality is significantly higher in patients with AVR (5.7%) than those with MVR (3.3%). Patients with CABG are at higher risk of myocardial infarction (MI) compared to the ones without CABG (0.8% vs. 0.1%). No significant interaction was observed between the type of valve surgery (AVR/MVR) or valve surgery combinations (valve/valve + CABG) ( p ‐values = .81 vs. .97, respectively). Post‐operative outcomes in patients with overweight/obesity depend on several factors such as type of valve involved and presence of CABG. Risk management can lower the rate of mortality and morbidity in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
- Research Center for Advanced Technologies in Cardiovascular Medicine, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
- Cardiovascular Diseases Research Institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
- Cardiac Primary Prevention Research Center, Cardiovascular Disease Research Institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Nadia Rajablou
Zitieren
APA
Rajablou, N., Tashak Golroudbari, H., Ahmadi Tafti, S. H., Bagheri, J., Zoroufian, A., Sahebjam, M., Salehbeigi, S., Lesani, Z., & Omidi, N. (2025). Mid‐term outcomes of valve replacement surgery with or without coronary artery bypass grafting in patients with overweight and obesity: A cohort study. Clinical Obesity. https://doi.org/10.1111/cob.12710
Vancouver
Rajablou N, Tashak Golroudbari H, Ahmadi Tafti SH, Bagheri J, Zoroufian A, Sahebjam M, et al. Mid‐term outcomes of valve replacement surgery with or without coronary artery bypass grafting in patients with overweight and obesity: A cohort study. Clinical Obesity. 2025. doi:10.1111/cob.12710
BibTeX
@article{Rajablou2025,
author = {Rajablou, Nadia and Tashak Golroudbari, Hasti and Ahmadi Tafti, Seyed Hossein and Bagheri, Jamshid and Zoroufian, Arezou and Sahebjam, Mohammad and Salehbeigi, Shahrzad and Lesani, Zohreh and Omidi, Negar},
title = {Mid‐term outcomes of valve replacement surgery with or without coronary artery bypass grafting in patients with overweight and obesity: A cohort study},
journal = {Clinical Obesity},
year = {2025},
doi = {10.1111/cob.12710}
}
EUVIMED